XML 28 R19.htm IDEA: XBRL DOCUMENT v3.23.1
The Company and Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2023
Accounting Policies [Abstract]  
Summary of Cash and Cash Equivalents and Restricted Cash

The Company's cash and cash equivalents and restricted cash, as presented in the Consolidated Statements of Cash Flows, was as follows (in thousands):

 

 

As of

 

 

March 31,

 

 

2023

 

 

2022

 

Cash and cash equivalents

$

141,455

 

 

$

126,574

 

Restricted cash

 

757

 

 

 

749

 

Total as presented in the Consolidated Statements of Cash Flows

$

142,212

 

 

$

127,323

 

Summary of Non-Vested Restricted Stock Units Granted

The following is a summary of non-vested restricted stock units granted (in thousands, except grant date fair value data):

 

 

 

Three-Month Period

 

 

 

Ended March 31,

 

 

 

2023

 

 

2022

 

Restricted stock units granted

 

 

3,614

 

 

53

 

Weighted average fair value

 

$

6.63

 

 

$

6.06

 

Reconciliation of Basic and Diluted Income (Loss) Per Share

The following table illustrates the reconciliation of the basic and diluted income (loss) per share (in thousands, except share and per share data):

 

 

 

Three-Month Period

 

 

 

Ended March 31,

 

 

 

2023

 

 

2022

 

Basic earnings per share:

 

 

 

 

 

 

Numerator:

 

 

 

 

 

 

Net income (loss) attributable to common stockholders

 

$

2,041

 

 

$

1,887

 

 

 

 

 

 

 

 

Denominator:

 

 

 

 

 

 

Weighted average common shares outstanding

 

 

87,623,887

 

 

 

86,522,378

 

 

 

 

 

 

 

 

Per share:

 

 

 

 

 

 

Net income (loss) per share attributable to common stockholders

 

$

0.02

 

 

$

0.02

 

 

 

 

 

 

 

 

Diluted earnings per share:

 

 

 

 

 

 

Numerator:

 

 

 

 

 

 

Net income (loss) attributable to common stockholders

 

$

2,041

 

 

$

1,887

 

 

 

 

 

 

 

 

Denominator:

 

 

 

 

 

 

Weighted average common shares outstanding

 

 

87,623,887

 

 

 

86,522,378

 

Dilutive securities:

 

 

 

 

 

 

Stock options and restricted stock units

 

 

2,162,698

 

 

 

2,107,838

 

Diluted shares outstanding

 

 

89,786,585

 

 

 

88,630,216

 

 

 

 

 

 

 

 

Per share:

 

 

 

 

 

 

Net income (loss) per share attributable to common stockholders

 

$

0.02

 

 

$

0.02

 

Fair Value of Assets and Liabilities Measured on Recurring Basis and Nonrecurring Basis

The following table presents the Company’s financial assets and liabilities measured at fair value on a recurring and nonrecurring basis in the condensed consolidated balance sheets (in millions):

 

March 31, 2023

Total Fair Value

and Carrying

Value on

Balance Sheet

Fair Value Measurement Category

 

 

 

Recurring fair value measurements

Level 1

Level 2

Level 3

 

 

Total Gains (Losses)

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market account

 

$

8.2

 

 

$

8.2

 

 

$

 

 

$

 

 

 

 

Corporate bonds and notes

 

$

36.5

 

 

 

 

 

$

36.5

 

 

 

 

 

 

 

Asset-backed securities

 

$

1.2

 

 

 

 

 

$

1.2

 

 

 

 

 

 

 

U.S. Government securities

 

$

0.7

 

 

 

 

 

$

0.7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contingent consideration

 

$

59.7

 

 

$

 

 

 

 

 

$

59.7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2022

Total Fair Value

and Carrying

Value on

Balance Sheet

Fair Value Measurement Category

 

 

 

Recurring fair value measurements

Level 1

Level 2

Level 3

 

 

Total Gains (Losses)

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market account

 

$

1.4

 

 

$

1.4

 

 

$

 

 

$

 

 

 

 

Corporate bonds and notes

 

$

44.5

 

 

 

 

 

$

44.5

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contingent consideration

 

$

63.8

 

 

$

 

 

 

 

 

$

63.8

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nonrecurring fair value measurements:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

FCC licenses

 

$

24.5

 

 

 

 

 

 

 

 

$

24.5

 

$

(1.6

)

Summary of Amortized Cost and Unrealized Gains (Losses) of Available for Sale Securities

As of March 31, 2023, the following table summarizes the amortized cost and the unrealized gains (losses) of the available for sale securities (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate Bonds and Notes

 

 

Asset-Backed Securities

 

 

U.S. Government securities

 

 

 

Amortized Cost

 

 

Unrealized gains (losses)

 

 

Amortized Cost

 

 

Unrealized gains (losses)

 

 

Amortized Cost

 

 

Unrealized gains (losses)

 

Due within a year

 

$

12,712

 

 

$

(98

)

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

Due after one year

 

 

24,434

 

 

 

(567

)

 

 

1,153

 

 

 

(1

)

 

 

734

 

 

 

-

 

Total

 

$

37,146

 

 

$

(665

)

 

$

1,153

 

 

$

(1

)

 

$

734

 

 

$

-

 

Summary of Changes in Contingent Consideration The following table presents the changes in the contingent consideration (in millions):

 

 

Three-Month Period

 

 

Ended March 31,

 

 

2023

 

 

2022

 

Beginning balance

$

63.8

 

 

$

114.9

 

Payments to sellers

 

-

 

 

 

(14.7

)

(Gain) loss recognized in earnings

 

(4.1

)

 

 

5.1

 

Ending balance

$

59.7

 

 

$

105.3

 

Summary of Components of AOCI

The following table provides a roll-forward of accumulated other comprehensive income (loss) (in thousands):

 

 

 

Foreign
Currency
Translation

 

 

Marketable
Securities

 

 

Total

 

Accumulated other comprehensive income (loss) as of December 31, 2022

 

$

(1,345

)

 

$

(165

)

 

$

(1,510

)

Other comprehensive income (loss)

 

 

16

 

 

 

138

 

 

 

154

 

Income tax (expense) benefit

 

 

-

 

 

 

(35

)

 

 

(35

)

Amounts reclassified from AOCI

 

 

-

 

 

 

31

 

 

 

31

 

Income tax (expense) benefit

 

 

-

 

 

 

(8

)

 

 

(8

)

Other comprehensive income (loss), net of tax

 

 

16

 

 

 

126

 

 

 

142

 

Accumulated other comprehensive income (loss) as of March 31, 2023

 

 

(1,329

)

 

 

(39

)

 

 

(1,368

)